Send to

Choose Destination
See comment in PubMed Commons below
Cancer Res Treat. 2011 Jun;43(2):108-16. doi: 10.4143/crt.2011.43.2.108. Epub 2011 Jun 30.

An association study of polymorphisms in JAK3 gene with lung cancer in the Korean population.

Author information

Brain Korea 21 Project for Biomedical Science, Seoul, Korea.



The genetic alteration of the janus kinases (JAKs), non-receptor tyrosine kinase, is related to the development of human cancers. However, little is known about how the sequence variation of JAK3 contributes to the development of lung cancer. This study investigated whether polymorphisms at the promoter region of the JAK3 gene are associated with the risk of lung cancer in the Korean population.


A total of 819 subjects, including 409 lung cancer patients and 410 healthy controls were recruited. The SNaPshot assay and polymerase chain reaction-restriction fragment length polymorphism analysis were used, and logistic regression analyses were performed to characterize the association between polymorphisms of JAK3 and lung cancer risk.


Three polymorphisms (-672 G>A, +64 A>G and +227 G>A) of JAK3 were analyzed for large-scale genotyping (n=819). Statistical analyses revealed that polymorphisms and haplotypes in the JAK3 gene were not significantly associated with lung cancer.


JAK3 gene was not significantly associated with the risk of lung cancer in the Korean population.


Haplotypes; Janus kinase 3; Korea; Lung cancer; Polymorphism

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Publishing M2Community Icon for PubMed Central
    Loading ...
    Support Center